ConductScience.org, home

Paper42423946

An Eight-Century Evolution of Asthma Therapeutics in Western Countries: From Medieval Regimens to Anti-inflammatory Reliever Therapy and Precision Biologics.

Molfino NA and 1 other. Adv Ther, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. An Eight-Century Evolution of Asthma Therapeutics in Western Countries: From Medieval Regimens to Anti-inflammatory Reliever Therapy and Precision Biologics. Papers, record 42423946. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42423946

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
An Eight-Century Evolution of Asthma Therapeutics in Western Countries: From Medieval Regimens to Anti-inflammatory Reliever Therapy and Precision Biologics.
PubMed
Journal
Adv Ther
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review, Historical Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-10-01
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Molfino NANestor Ahttps://orcid.org/0009-0004-8553-9167
2O'Byrne PMPaul M

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AsthmaMajor topic
Biological ProductsMajor topic
Anti-Inflammatory AgentsMajor topic
Anti-Asthmatic AgentsMajor topic
Humans
History, 20th Century
History, Medieval
Bronchodilator Agents
History, 21st Century
History, 19th Century
Adrenal Cortex Hormones
Precision Medicine

Source PubMed

Download CSV of topics

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14184208Rise and fall of asthma mortality in England and Wales in relation to use of pressurised aerosols.Lancet1969https://conductscience.org/library/papers/4184208PubMed
22565417Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study.Lancet1989https://conductscience.org/library/papers/2565417PubMed
317636617Corticosteroids for preventing relapse following acute exacerbations of asthma.Cochrane Database Syst Rev2007https://conductscience.org/library/papers/17636617PubMed
440186378Touching a Nerve: Neuroimmune Interactions in Asthma.Immunol Rev2025https://conductscience.org/library/papers/40186378PubMed
536754956Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update.NPJ Prim Care Respir Med2023https://conductscience.org/library/papers/36754956PubMed
617092772A brief history of inhaled asthma therapy over the last fifty years.Prim Care Respir J2006https://conductscience.org/library/papers/17092772PubMed
739615502Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial.Lancet Respir Med2025https://conductscience.org/library/papers/39615502PubMed
812324675Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma.Thorax2002https://conductscience.org/library/papers/12324675PubMed
925445859A randomized trial of benralizumab, an antiinterleukin 5 receptor α monoclonal antibody, after acute asthma.Am J Emerg Med2015https://conductscience.org/library/papers/25445859PubMed
1127748638The History of Therapeutic Aerosols: A Chronological Review.J Aerosol Med Pulm Drug Deliv2017https://conductscience.org/library/papers/27748638PubMed
127025335Moses Maimonides' treatise on asthma.Thorax1981https://conductscience.org/library/papers/7025335PubMed
1312535399Self-management education and regular practitioner review for adults with asthma.Cochrane Database Syst Rev2003https://conductscience.org/library/papers/12535399PubMed
14332807092020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group.J Allergy Clin Immunol2020https://conductscience.org/library/papers/33280709PubMed
1538657997Biologic agents licensed for severe asthma: a systematic review and meta-analysis of randomised controlled trials.Eur Respir Rev2024https://conductscience.org/library/papers/38657997PubMed
1631249014GINA 2019: a fundamental change in asthma management: Treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescents.Eur Respir J2019https://conductscience.org/library/papers/31249014PubMed
172221590Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics.Am Rev Respir Dis1990https://conductscience.org/library/papers/2221590PubMed
181986288Respiratory arrest in near-fatal asthma.N Engl J Med1991https://conductscience.org/library/papers/1986288PubMed
1910922423Low-dose inhaled corticosteroids and the prevention of death from asthma.N Engl J Med2000https://conductscience.org/library/papers/10922423PubMed
2030185653Eosinophils increase airway sensory nerve density in mice and in human asthma.Sci Transl Med2018https://conductscience.org/library/papers/30185653PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42423946

GET https://conductscience.org/api/papers/v1/42423946/authors